IL6 and breast cancer: Correlation analysis between plasma cytokine levels and clinicopathological features revealed that elevated levels of IFN-γ, IL-1β, IL-2, IL-6, and IL-12 (p40) were significantly associated with advanced clinical stages of breast cancer (P < 0.05).